Co-delivery of doxorubicin and methotrexate by dendritic chitosan-g-mPEG as a magnetic nanocarrier for multi-drug delivery in combination chemotherapy
Polymer Chemistry2017Vol. 8(47), pp. 7333–7350
Citations Over TimeTop 10% of 2017 papers
Abstract
Nanoparticulate drug delivery systems have the potential to improve the therapeutic efficacy of anticancer agents, and combination therapy is a promising strategy for clinical cancer treatment with synergistic effects.
Related Papers
- → Design and Fabrication of Magnetically Responsive Nanocarriers for Drug Delivery(2016)83 cited
- → Engineered Nanocarriers of Doxorubicin: A Current Update(2008)92 cited
- → Application and Perspective of pH-Responsive Nano Drug Delivery Systems(2018)23 cited
- → Targeted drug release from stable and safe ultrasound-sensitive nanocarriers(2021)2 cited
- → Nanotechnologies for Ocular Surface Disorder Management: A Promising Approach(2005)